Filing Flows › Biolife Solutions (BLFS) › Q1 2026
Biolife Solutions (BLFS) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Biolife Solutions (BLFS) reported revenue of $27.5M for the first quarter 2026 (Q1 2026), +25% from a year earlier and +46% from the quarter before. Operating margin was 0.1%, net earnings $1.2M (4.3% of revenue).
Biolife Solutions, Q1 2026: revenue $27.5M (+25% year over year), operating margin 0.1%, net earnings $1.2M, operating cash flow −$491K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.5M | +46% | +25% |
| Gross profit | $17.5M | — | +18% |
| Operating profit | $27K | -98% | — |
| Net earnings | $1.2M | -89% | — |
| Operating cash flow | −$491K | -110% | -128% |
What changed
Revenue was $27.5M in Q1 2026, up 25% year over year and up 46% from the previous quarter.
Gross margin was 63.6%, down 3.5 points from Q1 2025. Operating profit was $27K, a 0.1% margin (up 2.4 points year over year). Operating expenses grew 14% against revenue growth of 25%. The fastest-growing cost line was Research & development (+84%). Net earnings were $1.2M. The effective tax rate was 5.0%. Non-operating items added $1.2M, 98% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$491K. Non-cash charges added back $374K of depreciation and amortization and $4.8M of share-based compensation. Working capital and other items used $6.9M. Capital expenditures of $167K exceeded it, leaving free cash flow of −$658K.
Questions
What was Biolife Solutions' revenue in the first quarter 2026?
Biolife Solutions (BLFS) reported revenue of $27.5M for the first quarter 2026 (Q1 2026), +25% from a year earlier and +46% from the quarter before.
Was Biolife Solutions profitable in the first quarter 2026?
Operating profit was $27K (0.1% of revenue) and net earnings $1.2M.
Source: Biolife Solutions 10-Q on SEC EDGAR.